vs
Side-by-side financial comparison of DOMO, INC. (DOMO) and Vericel Corp (VCEL). Click either name above to swap in a different company.
Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $79.4M, roughly 1.2× DOMO, INC.). Vericel Corp runs the higher net margin — 25.0% vs -13.1%, a 38.1% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs -0.5%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $1.1M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs -0.5%).
Domo, Inc. is an American cloud software company based in American Fork, Utah, United States. It specializes in artificial intelligence, business intelligence, and data visualization and is designed to provide real-time access to business data for decision makers across the company with minimal IT involvement. It is a Software-as-a-Service (SaaS) venture.
Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.
DOMO vs VCEL — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $79.4M | $92.9M |
| Net Profit | $-10.4M | $23.2M |
| Gross Margin | 74.2% | 78.7% |
| Operating Margin | -8.7% | 24.1% |
| Net Margin | -13.1% | 25.0% |
| Revenue YoY | -0.5% | 23.3% |
| Net Profit YoY | 44.6% | 17.3% |
| EPS (diluted) | $-0.25 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $79.4M | $92.9M | ||
| Q3 25 | $79.7M | $67.5M | ||
| Q2 25 | $80.1M | $63.2M | ||
| Q1 25 | $78.8M | $52.6M | ||
| Q4 24 | $79.8M | $75.4M | ||
| Q3 24 | $78.4M | $57.9M | ||
| Q2 24 | $80.1M | $52.7M | ||
| Q1 24 | $80.2M | $51.3M |
| Q4 25 | $-10.4M | $23.2M | ||
| Q3 25 | $-22.9M | $5.1M | ||
| Q2 25 | $-18.1M | $-553.0K | ||
| Q1 25 | $-17.7M | $-11.2M | ||
| Q4 24 | $-18.8M | $19.8M | ||
| Q3 24 | $-19.5M | $-901.0K | ||
| Q2 24 | $-26.0M | $-4.7M | ||
| Q1 24 | $-18.7M | $-3.9M |
| Q4 25 | 74.2% | 78.7% | ||
| Q3 25 | 74.8% | 73.5% | ||
| Q2 25 | 74.2% | 73.7% | ||
| Q1 25 | 74.4% | 69.0% | ||
| Q4 24 | 75.0% | 77.6% | ||
| Q3 24 | 74.3% | 71.9% | ||
| Q2 24 | 74.1% | 69.5% | ||
| Q1 24 | 76.3% | 68.9% |
| Q4 25 | -8.7% | 24.1% | ||
| Q3 25 | -9.1% | 5.1% | ||
| Q2 25 | -17.9% | -3.2% | ||
| Q1 25 | -15.6% | -24.3% | ||
| Q4 24 | -13.9% | 24.5% | ||
| Q3 24 | -18.5% | -4.3% | ||
| Q2 24 | -26.8% | -11.5% | ||
| Q1 24 | -16.6% | -10.7% |
| Q4 25 | -13.1% | 25.0% | ||
| Q3 25 | -28.8% | 7.5% | ||
| Q2 25 | -22.5% | -0.9% | ||
| Q1 25 | -22.4% | -21.4% | ||
| Q4 24 | -23.5% | 26.3% | ||
| Q3 24 | -24.9% | -1.6% | ||
| Q2 24 | -32.5% | -8.9% | ||
| Q1 24 | -23.3% | -7.5% |
| Q4 25 | $-0.25 | $0.46 | ||
| Q3 25 | $-0.56 | $0.10 | ||
| Q2 25 | $-0.45 | $-0.01 | ||
| Q1 25 | $-0.45 | $-0.23 | ||
| Q4 24 | $-0.48 | $0.40 | ||
| Q3 24 | $-0.51 | $-0.02 | ||
| Q2 24 | $-0.69 | $-0.10 | ||
| Q1 24 | $-0.51 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $137.5M |
| Total DebtLower is stronger | $124.2M | — |
| Stockholders' EquityBook value | $-191.9M | $354.6M |
| Total Assets | $201.6M | $488.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $137.5M | ||
| Q3 25 | — | $135.4M | ||
| Q2 25 | $47.2M | $116.9M | ||
| Q1 25 | $45.3M | $112.9M | ||
| Q4 24 | — | $116.2M | ||
| Q3 24 | — | $101.7M | ||
| Q2 24 | $61.2M | $102.5M | ||
| Q1 24 | $60.9M | $110.6M |
| Q4 25 | $124.2M | — | ||
| Q3 25 | $121.9M | — | ||
| Q2 25 | $119.7M | — | ||
| Q1 25 | $117.7M | — | ||
| Q4 24 | $115.6M | — | ||
| Q3 24 | $115.2M | — | ||
| Q2 24 | $114.1M | — | ||
| Q1 24 | $113.5M | — |
| Q4 25 | $-191.9M | $354.6M | ||
| Q3 25 | $-191.5M | $321.9M | ||
| Q2 25 | $-178.7M | $306.8M | ||
| Q1 25 | $-177.2M | $295.5M | ||
| Q4 24 | $-171.2M | $292.0M | ||
| Q3 24 | $-166.4M | $257.5M | ||
| Q2 24 | $-163.5M | $243.0M | ||
| Q1 24 | $-153.5M | $233.9M |
| Q4 25 | $201.6M | $488.0M | ||
| Q3 25 | $195.7M | $453.3M | ||
| Q2 25 | $189.7M | $435.6M | ||
| Q1 25 | $214.3M | $424.6M | ||
| Q4 24 | $190.2M | $432.7M | ||
| Q3 24 | $197.8M | $390.4M | ||
| Q2 24 | $204.4M | $376.8M | ||
| Q1 24 | $225.7M | $356.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.4M | $15.0M |
| Free Cash FlowOCF − Capex | $1.1M | $12.8M |
| FCF MarginFCF / Revenue | 1.4% | 13.8% |
| Capex IntensityCapex / Revenue | 2.9% | 2.4% |
| Cash ConversionOCF / Net Profit | — | 0.65× |
| TTM Free Cash FlowTrailing 4 quarters | $9.9M | $24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.4M | $15.0M | ||
| Q3 25 | $3.4M | $22.1M | ||
| Q2 25 | $4.0M | $8.2M | ||
| Q1 25 | $8.9M | $6.6M | ||
| Q4 24 | $-13.7M | $22.2M | ||
| Q3 24 | $-6.2M | $10.2M | ||
| Q2 24 | $1.9M | $18.5M | ||
| Q1 24 | $5.4M | $7.2M |
| Q4 25 | $1.1M | $12.8M | ||
| Q3 25 | $1.0M | $19.5M | ||
| Q2 25 | $1.0M | $81.0K | ||
| Q1 25 | $6.7M | $-7.6M | ||
| Q4 24 | $-16.2M | $8.5M | ||
| Q3 24 | $-8.4M | $-9.2M | ||
| Q2 24 | $-625.0K | $1.8M | ||
| Q1 24 | $2.9M | $-6.8M |
| Q4 25 | 1.4% | 13.8% | ||
| Q3 25 | 1.3% | 28.8% | ||
| Q2 25 | 1.3% | 0.1% | ||
| Q1 25 | 8.5% | -14.5% | ||
| Q4 24 | -20.3% | 11.2% | ||
| Q3 24 | -10.7% | -15.9% | ||
| Q2 24 | -0.8% | 3.4% | ||
| Q1 24 | 3.6% | -13.3% |
| Q4 25 | 2.9% | 2.4% | ||
| Q3 25 | 2.9% | 3.9% | ||
| Q2 25 | 3.7% | 12.9% | ||
| Q1 25 | 2.8% | 27.0% | ||
| Q4 24 | 3.2% | 18.3% | ||
| Q3 24 | 2.8% | 33.5% | ||
| Q2 24 | 3.2% | 31.8% | ||
| Q1 24 | 3.1% | 27.3% |
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
